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of chikungunya and Zika viruses and into the New World 
at approximately the same time. Further studies might elu-
cidate the exact mechanism of this transcontinental move-
ment, leading to effective prevention strategies.
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To the Editor: Sleeping sickness, or human African 
trypanosomiasis, is a neglected tropical parasitic infection 
transmitted by the tsetse fly bite. In central and western Af-
rica, trypanosomiasis is caused by the Trypanosoma brucei 
subspecies gambiense. Chronic symptoms of the disease 
include neurologic impairment and sleep disorders (1). 
Infected children and adults can exhibit other nonspecific 
symptoms (1,2) attributable to biologic inflammatory syn-
drome, usually accompanied by an increase of IgM. Sleep-
ing sickness can be fatal if left untreated (3). Although the 
efforts of the World Health Organization (WHO), national 
control programs, and nongovernmental organizations such 
as Médecins Sans Frontières have substantially reduced the 
global burden of human African trypanosomiasis, its cur-
rent annual incidence is still estimated to be ≈10,000 new 
cases (1,4). Most cases occur during long stays in trypano-
somiasis-endemic areas. Rare alternative routes of trans-
mission are possible in nonendemic areas (e.g., through 
blood transfusion or organ transplantation) (5). We report 
the case of a 14-month-old boy infected with Tr. brucei 
through the transplacental route.
The child was referred to a pediatric care unit because 
of psychomotor retardation and axial hypotonia. His moth-
er was from the Democratic Republic of the Congo (DRC) 
and had arrived in France 3 years earlier. The pregnancy, 
which had been initiated and monitored in France, was nor-
mal through delivery. Nonetheless, the newborn was placed 
with a foster family because his mother had vigilance dis-
orders, aphasia, fluctuating hemiparesia and tetraparesia, 
convulsions associated with choreiform movements, anxi-
ety, and severe depression. The foster family reported that 
the child did not smile and had been unable to grasp objects 
in the last 8 months. 
Clinical examination showed z-scores of –2.25 SD 
and –1.38 SD for height and weight, respectively; multiple 
lymph node enlargement; and absence of tendon reflexes. 
Intermittent fever and dystonic movements were reported 
later during a subsequent hospitalization. The results from 
blood tests were compatible with chronic inflammatory 
syndrome (albumin 28 g/L; hypergammaglobulinemia with 
IgM 7.38 g/L and IgG 31.3 g/L; leukocytes 20.9 g/L; hemo-
globin concentration 98 g/L). Cranial magnetic resonance 
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imaging showed several lesions of the white matter, mostly 
in the left frontotemporal lobe. The boy’s cerebrospinal 
fluid (CSF) contained glucose at 2.5 mmol/L, protein at 
0.88 g/L, and 125 leukocytes/mL (100% lymph cells). Mi-
croscopic observation of CSF and blood smear highlighted 
Tr. brucei trypomastigotes (Figure, panels A and B; Video, 
http://wwwnc.cdc.gov/EID/article/22/5/16-0133-V1.htm).
All the clinical and biologic findings were compatible 
with a diagnosis of autochthonous congenital trypanoso-
miasis in the meningo-encephalitic second stage. In ad-
dition to diffuse bilateral lesions of her white matter and 
biologic inflammatory syndrome, the mother also exhibited 
the same neurologic symptoms as the boy, at least since her 
last stay in DRC, a trypanosomiasis-endemic country that 
currently harbors ≈90% of new cases of African trypanoso-
miasis worldwide (6). She previously lived in Kinshasa and 
also reported a short visit into the bush in Angola. Until try-
pomastigotes were observed in her son’s CSF, the mother 
had not received a definitive diagnosis. She was thereaf-
ter invited for clinical and laboratory examination. Lum-
bar puncture and blood tests were then performed: Mott 
cells were present in her CSF, but no parasite was detected 
(Figure, panel C). Diagnosis of trypanosomiasis was sub-
sequently supported by positive serologic test results (7).
The 2 patients were administered 400 mg/kg eflorni-
thine monotherapy (difluoromethylornithine) daily for 2 
weeks (8,9). The clinical outcome was globally satisfac-
tory for the mother. Her serologic tests remained positive 8 
months after treatment, which is long but not unusual, and 
confirms that serologic testing is unreliable for postthera-
peutic follow up (4,7). Magnetic resonance imaging showed 
a substantial decrease of her brain lesions. Her son still 
exhibited serious neurologic sequelae, although trypomasti-
gotes quickly disappeared from his CSF after treatment. He 
still had a restricted grip, axial hypotonia, and peripheral hy-
pertonus 2 years later. To date, he has limited contact with his 
environment and is not able to stand up or eat alone.
Altogether, this case is exceptional for 2 reasons: 1) 
the diagnosis of human African trypanosomiasis in adults 
and children is very unusual in countries where the disease 
is not endemic (<100 cases are estimated to have occurred 
over a 10-year period) (10); and 2) congenital transmis-
sion seems to be extremely rare, even in Africa (2). To our 
knowledge, 17 probable cases of congenital trypanosomia-
sis have been reported to date, but only 14 were sufficiently 
described to confirm mother-to-fetus transmission (13 were 
attributed to Tr. brucei gambiense, and 1 was attributed to 
Tr. brucei rhodesiense, the eastern African subspecies) (2). 
Because not all official guidelines mention this route of 
transmission, the incidence of congenital trypanosomiasis 
is thought to be underestimated (4).
The diagnosis of human trypanosomiasis should al-
ways be considered for persons who have neurologic and 
sleep disorders and have spent time in sub-Saharan Africa 
as soon as infection is suspected. Congenital trypanosomia-
sis is rarely studied, and incidence data are limited; how-
ever, because this is another possible route of infection, 
even when infection of the fetus occurs long after infection 
of the mother, we believe congenital transmission occurs 
more often than suspected.
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Figure. A) Cytological slide prepared from cerebrospinal fluid (CSF) from a child with congenital trypanosomiasis who was born in 
France to an African mother (Gram staining, original magnification ×1,000). B) Blood smear from the child (May-Grunewald Giemsa 
[MGG] staining, original magnification ×1,000). C) Mott cell in the mother’s CSF (MGG staining, original magnification ×1,000). 
Trypomastigote forms of Trypanosoma brucei are extracellular structures, 2 × 25 µm, with a terminal flagellum (gray arrow, panel A), 
which is prolonged by an undulating membrane (black arrow, panel A). A central nucleus, which was difficult to visualize by Gram 
staining, shows that the microorganism is eukaryote. The kinetoplast (arrow, panel B) is more visible by MGG staining. It is a small 
organelle at the end of the cell that permits the synchronous movement of the flagellum and the undulating membrane. The kinetoplast 
contains circular mitochondrial DNA (1). The numerous mononuclear cells in CSF and blood are activated lymphocytes. The Mott cell 
(arrow, panel C) is a plasma cell that has spherical inclusions packed into its cytoplasm. It is often found in human trypanosomiasis (3). 
Diagnosis was subsequently confirmed by PCR. Video available online http://wwwnc.cdc.gov/eid/article/22/5/16-0133-vid1.
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To the Editor: Zika virus is an emerging arbovirus 
spread by Aedes aegypti mosquitoes and belongs to the 
genus Flavivirus of the Spondweni serocomplex (1,2). 
Most often, signs and symptoms of infection are macu-
lopapular rash, fever, arthralgia, myalgia, headache, and 
conjunctivitis; edema, sore throat, cough, and vomiting 
occur less frequently. 
Zika virus is an RNA virus containing 10,794 nt, and 
diagnostic tests include PCRs on acute-phase serum sam-
ples to detect viral RNA (1). The genome contains 5′ and 
3′ untranslated regions flanking a single open reading 
frame (ORF) that encodes a polyprotein that is cleaved 
into the structural proteins capsid (C), premembrane/
membrane (prM), and envelope (E), and 8 non-structural 
proteins (NS1, NS2A, NS2B, NS3, NS4A, 2K, NS4B, 
and NS5) (3). Genetic studies in which nucleotide se-
quences derived from the NS5 gene were used indicated 
3 Zika virus lineages: East African, West African, and 
Asian (4,5). 
In Brazil, the first identified cases of dengue-like 
syndrome with subsequent Zika virus confirmation were 
documented in the early months of 2015 in the state of 
Rio Grande do Norte (6). Later that year, autochthonous 
transmission was reported in Colombia and Suriname dur-
ing October–November (5) and Puerto Rico in December 
(6,7). During the same period, imported cases in the Unit-
ed States and Mexico were reported (6). By December 
2015, we had already identified at least 15 autochthonous 
and 1 imported Zika cases in Mexico, initially detected by 
real-time reverse transcription PCR (RT-PCR). Here, we 
report on the documentation of a case of Zika virus infec-
tion in a male traveler returning to Mexico from Colombia 
in October 2015. 
On October 21, 2015, we identified an imported 
case of Zika virus infection in the central state of Queré-
taro, Mexico. The patient, a 26-year-old man, had visited 
Santa Martha, Colombia, during the previous 12 days. 
Symptoms including fever, muscle pain, mild to moder-
ate arthralgia, arthritis, back pain, chills, and conjuncti-
vitis began on October 19, two days after his return to 
Mexico. A sample was collected at a primary healthcare 
clinic. Initial molecular testing for dengue virus at the 
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